London Pharma Capital Limited in London, W1U 7BU

Description

Data updated on: 01-11-2023

The official moment this company was started is 2015-03-10. Started under no. 09482452, this firm is listed as a Private Limited Company. You may visit the headquarters of this company during office times under the following location: Fifth Floor Watson House 54-60 Baker Street, W1U 7BU London. Established as Wagosi, this firm used the business name until 2015, when it got changed to London Pharma Capital Limited. This firm's classified under the NACE and SIC code 21200 and has the NACE code: Manufacture of pharmaceutical preparations. Thursday 29th December 2022 is the last time company accounts were reported.

The following firm owes its well established position on the market and constant progress to exactly two directors, namely Simon D. and Ivan B., who have been managing the company since January 2016.

Ivan B. is the individual who controls this firm, owns over 1/2 to 3/4 of company shares .

Previous company's names
London Pharma Capital Limited 2015-11-04
Wagosi Limited 2015-03-10

Financial data based on annual reports

Profit & Loss
Date of Accounts	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-30	2022-12-29
Currency
Net Worth	1

Balance Sheet
Cash Bank On Hand		21 043	40 554	249 249	221 526	749 385
Current Assets		49 007	250 300	614 048	575 345	1 157 501	1 157 501	1 157 501
Debtors		27 964	209 746	364 799	353 819	408 116
Net Assets Liabilities		56 719	-4 926	437 362		735 616	735 616	735 616
Other Debtors				40 552	169 871	265 835
Cash Bank In Hand	1
Net Assets Liabilities Including Pension Asset Liability	1

Capital & Reserves
Shareholder Funds	1

Other Financial Data
Amounts Owed By Related Parties				142 281	142 281	142 281
Average Number Employees During Period				3	4	1	2	2
Comprehensive Income Expense		-32 033	-61 645	442 288
Corporation Tax Payable					8 924
Creditors		6 040	268 978	181 688	15 473	426 512	426 512	426 512
Fixed Assets		13 752	13 752	5 002		4 627	4 627	4 627
Income Expense Recognised Directly In Equity		88 751
Investments		13 752	13 752	5 002
Investments Fixed Assets		13 752	13 752	5 002	5 002	4 627
Investments In Group Undertakings Participating Interests				5 002	5 002	4 627
Issue Equity Instruments		88 751
Net Current Assets Liabilities		42 967	-18 678	432 360	559 872	730 989	730 989	730 989
Other Creditors				181 688	6 549	426 512
Profit Loss		-32 033	-61 645	442 288
Total Assets Less Current Liabilities		56 719	-4 926	437 362	564 874	735 616	735 616	735 616
Trade Debtors Trade Receivables				181 966	41 667
Advances Credits Directors		3 040	2 978	2 678
Advances Credits Made In Period Directors		3 640
Advances Credits Repaid In Period Directors		600	62	300
Number Shares Allotted	1
Par Value Share	1
Share Capital Allotted Called Up Paid	1

Company staff

Simon D.

Role: Director

Appointed: 07 January 2016

Latest update: 10 February 2024

Ivan B.

Role: Director

Appointed: 10 March 2015

Latest update: 10 February 2024

People with significant control

Ivan B.

Notified on 6 April 2016

Nature of control:

over 1/2 to 3/4 of shares

Accounts Documents

Account next due date	29 September 2024
Account last made up date	29 December 2022
Confirmation statement next due date	21 January 2024
Confirmation statement last made up date	07 January 2023

Annual Accounts 2 December 2016
Start Date For Period Covered By Report	2015-03-10
End Date For Period Covered By Report	2015-12-31
Date Approval Accounts	2 December 2016
Annual Accounts
Start Date For Period Covered By Report	2017-01-01
End Date For Period Covered By Report	31/12/2017
Annual Accounts
Start Date For Period Covered By Report	2018-01-01
End Date For Period Covered By Report	31/12/2018
Annual Accounts
Start Date For Period Covered By Report	2019-01-01
End Date For Period Covered By Report	2019-12-31
Annual Accounts
Start Date For Period Covered By Report	2020-01-01
End Date For Period Covered By Report	2020-12-31
Annual Accounts
Start Date For Period Covered By Report	2021-01-01
End Date For Period Covered By Report	2021-12-30
Annual Accounts
Start Date For Period Covered By Report	2021-12-31
End Date For Period Covered By Report	2022-12-29

London Pharma Capital Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Simon D.

Ivan B.

Jonathan F.

People with significant control

Ivan B.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Closest Companies - by postcode